PRELUDE CAPITAL MANAGEMENT, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,520
-82.7%
15,933
-62.4%
0.00%
-80.0%
Q1 2023$165,041
-17.1%
42,427
-27.5%
0.01%0.0%
Q4 2022$199,016
+168.9%
58,534
+333.9%
0.01%
+233.3%
Q3 2022$74,000
+39.6%
13,491
+14.4%
0.00%
+50.0%
Q2 2022$53,000
-60.7%
11,793
-43.8%
0.00%
-33.3%
Q4 2021$135,000
+10.7%
21,0000.0%0.00%0.0%
Q3 2021$122,000
-43.8%
21,0000.0%0.00%
-50.0%
Q2 2021$217,000
-1.8%
21,0000.0%0.01%0.0%
Q1 2021$221,000
-22.5%
21,000
+14.1%
0.01%
-14.3%
Q4 2020$285,000
+5.9%
18,4000.0%0.01%
-46.2%
Q3 2020$269,000
-25.3%
18,400
-3.3%
0.01%
-35.0%
Q2 2020$360,000
+11900.0%
19,025
+13686.2%
0.02%
Q4 2019$3,000
-66.7%
138
-90.9%
0.00%
Q2 2019$9,000
+350.0%
1,524
+383.8%
0.00%
Q1 2019$2,000
-33.3%
315
-11.8%
0.00%
Q4 2018$3,000
-62.5%
357
-28.0%
0.00%
Q3 2018$8,000
+60.0%
496
+78.4%
0.00%
Q2 2018$5,000
-81.5%
278
-86.1%
0.00%
-100.0%
Q1 2018$27,000
+35.0%
2,000
+11.1%
0.00%0.0%
Q3 2017$20,000
-93.4%
1,800
-94.4%
0.00%
-94.6%
Q4 2016$303,00032,1960.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders